Skip to main content

Hartman Curt R's Form 4 filing

CONMED Corp (CNMD) · filed Sep 17, 2021

Accession no.
0001127602-21-025509
Filed
Sep 17, 2021
Trade date
Sep 15-17, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $318.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hartman Curt RCIK 0001451535Director, Officer (President, CEO and Chair)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 15, 2021Common StockSSaleDisposed−2,500$127.39F1−$318,47564,980Direct
Sep 15, 2021Common StockMOption exerciseAcquired+34,000$39.87+$1,355,58098,980Direct
Sep 15, 2021Common StockFTax withholdingDisposed−19,349$127.24−$2,461,966.7679,631Direct
Sep 15, 2021Common StockMOption exerciseAcquired+47,500$41.93+$1,991,675127,131Direct
Sep 15, 2021Common StockFTax withholdingDisposed−28,182$127.28−$3,587,004.9698,949Direct
Sep 17, 2021Common StockGGiftDisposed−89,000$0.00$09,949Direct
Sep 17, 2021Common StockGGiftAcquired+89,000$0.00$089,000Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 15, 2021Common StockMOption exerciseDisposed−34,000$0.00$00Direct
Sep 15, 2021Common StockMOption exerciseDisposed−47,500$0.00$0111,650Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)